Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
Status:
Recruiting
Trial end date:
2025-10-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) properties of
antiretroviral (ARV) and anti-tuberculosis (TB) drugs administered during pregnancy and
postpartum.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Gilead Sciences International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network Merck Sharp & Dohme Corp. National Institute of Mental Health (NIMH) ViiV Healthcare